Factors in fl uencing bioequivalence evaluation of insulin biosimilars based on a structural equation model

HIGHLIGHTS

• who: . et al. from the Phanes Therapeutics, Inc, United States College of Pharmacy, Chongqing Medical University, Chongqing, China, Phase I Clinical Research have published the research work: Factors in fl uencing bioequivalence evaluation of insulin biosimilars based on a structural equation model, in the Journal: (JOURNAL)
• what: The authors aimed to explore the factors affecting the bioequivalence of two preparations using a multiple statistical model, thus providing a scientific basis for the review and approval of insulin biosimilars.
• how: The authors carried out the trial in accordance with the principles of the Declaration . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.